Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications
Diabetes & Metabolism Journal · 01.09.2025 · 49 (5) · 915-933
DOI: 10.4093/dmj.2025.0508 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.09.2025. Verfasst von Taeeun Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Communicable Diseases, Diabetes Complications, Diabetes Mellitus. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus predisposes individuals to a broad spectrum of infections. People with diabetes face a 1.5- to 4-fold increased risk of both common and severe infections, and infections remain the leading cause of morbidity and mortality. Chronic hyperglycemia impairs neutrophil chemotaxis, oxidative burst, and complement activation, while vascular insufficiency and neuropathy compromise tissue perfusion and barrier integrity. These defects, together with altered skin, mucosal, and gut microbiota, influence the marked susceptibility to urinary tract infections (especially renal abscess and emphysematous pyelonephritis), osteomyelitis, diabetic foot infections, pneumonia (including influenza), tuberculosis, skin and soft tissue infections, and lifethreatening syndromes such as emphysematous cholecystitis and rhino-orbital mucormycosis that are almost exclusive to people with diabetes. Outcomes from infections are worse in diabetes. Although the core therapeutic principles align with those for patients without diabetes, management should be individualized. Glycemic control should balance infection risk and hypoglycemia; antimicrobial dosing should account for renal function and drug interactions; and strict antimicrobial stewardship is required. If needed, prompt debridement and multidisciplinary intervention are necessary to mitigate complications and reduce mortality. Preventive care relies on comprehensive vaccination (influenza, pneumococcus, severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], hepatitis B, herpes zoster, and Tdap/Td) and regular foot surveillance with offloading to avert ulceration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
- Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Zitieren
APA
Kim, T., & Choi, S. H. (2025). Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications. Diabetes & Metabolism Journal, 49(5), 915-933. https://doi.org/10.4093/dmj.2025.0508
Vancouver
Kim T, Choi SH. Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications. Diabetes & Metabolism Journal. 2025;49(5):915-933. doi:10.4093/dmj.2025.0508
BibTeX
@article{Kim2025,
author = {Kim, Taeeun and Choi, Sang-Ho},
title = {Diabetes Mellitus and Infectious Diseases: Current Evidence and Clinical Implications},
journal = {Diabetes & Metabolism Journal},
year = {2025},
volume = {49},
number = {5},
pages = {915--933},
doi = {10.4093/dmj.2025.0508}
}
EUVIMED